|

vvDD-hIL-2-RG-1 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)1

Indications

  • Liver Disease1
  • MSS-CRC1
  • MSI-H1
  • Gastric Neoplasms1
  • Peritoneal Carcinoma1

Pittsburgh, Pennsylvania1 trial

Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

AHN West Penn Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.